137 related articles for article (PubMed ID: 1990605)
1. 15-Deoxyspergualin is a more potent and effective immunosuppressant than cyclosporine but does not effectively suppress lymphoproliferation in vivo.
Yuh DD; Morris RE
Transplant Proc; 1991 Feb; 23(1 Pt 1):535-9. PubMed ID: 1990605
[No Abstract] [Full Text] [Related]
2. Comparative studies on the immunosuppressive activity of FK506, 15-deoxyspergualin, and cyclosporine.
Ochiai T; Nakajima K; Sakamoto K; Nagata M; Gunji Y; Asano T; Isono K; Sakamaki T; Hamaguchi K
Transplant Proc; 1989 Feb; 21(1 Pt 1):829-32. PubMed ID: 2468228
[No Abstract] [Full Text] [Related]
3. The immunopharmacology of immunosuppression by 15-deoxyspergualin.
Yuh DD; Morris RE
Transplantation; 1993 Mar; 55(3):578-91. PubMed ID: 7681226
[TBL] [Abstract][Full Text] [Related]
4. A study of the contrasting effects of cyclosporine, FK 506, and rapamycin on the suppression of allograft rejection.
Morris RE; Wu J; Shorthouse R
Transplant Proc; 1990 Aug; 22(4):1638-41. PubMed ID: 1697111
[No Abstract] [Full Text] [Related]
5. Use of rapamycin for the suppression of alloimmune reactions in vivo: schedule dependence, tolerance induction, synergy with cyclosporine and FK 506, and effect on host-versus-graft and graft-versus-host reactions.
Morris RE; Meiser BM; Wu J; Shorthouse R; Wang J
Transplant Proc; 1991 Feb; 23(1 Pt 1):521-4. PubMed ID: 1703698
[No Abstract] [Full Text] [Related]
6. FK 506 and deoxyspergualin: additive immunosuppressive effect on rat cardiac allograft rejection in vivo and mitogen-stimulated human lymphocyte responses in vitro.
Jiang H; Takahara S; Li D; Namiki M; Ishibashi M; Okuyama A; Sonoda T
Transplant Proc; 1994 Aug; 26(4):2313-6. PubMed ID: 7520631
[No Abstract] [Full Text] [Related]
7. The effect of 15-deoxyspergualin on hamster-to-rat cardiac xenograft survival.
Pruitt SK; Halperin EC; Bollinger RR
Transplant Proc; 1991 Feb; 23(1 Pt 1):585-6. PubMed ID: 1990618
[No Abstract] [Full Text] [Related]
8. Effect of 15-deoxyspergualin on rejection detected by 31P nuclear magnetic resonance spectroscopy and in vivo mechanisms of action in rat heart transplantation.
Suzuki S; Kanashiro M; Watanabe H; Sakakibara I; Amemiya H
Transplant Proc; 1989 Feb; 21(1 Pt 1):1094-5. PubMed ID: 2523115
[No Abstract] [Full Text] [Related]
9. 15-Deoxyspergualin after cardiac and renal allotransplantation in primates.
Reichenspurner H; Hildebrandt A; Human PA; Boehm DH; Rose AG; Schorlemmer HU; Reichart B
Transplant Proc; 1990 Aug; 22(4):1618-9. PubMed ID: 2389423
[No Abstract] [Full Text] [Related]
10. Mycophenolic acid morpholinoethylester (RS-61443) is a new immunosuppressant that prevents and halts heart allograft rejection by selective inhibition of T- and B-cell purine synthesis.
Morris RE; Hoyt EG; Murphy MP; Eugui EM; Allison AC
Transplant Proc; 1990 Aug; 22(4):1659-62. PubMed ID: 2389428
[No Abstract] [Full Text] [Related]
11. 15-Deoxyspergualin and primate heart transplantation.
Kapelanski DP; Perelman MJ; Faber LA; Paez DE; Rose EF; Behrendt DM
J Heart Transplant; 1990; 9(6):668-73; discussion 673-4. PubMed ID: 2277306
[TBL] [Abstract][Full Text] [Related]
12. Effect of a new immunosuppressant, 15-deoxyspergualin, on heterotopic rat heart transplantation, in comparison with cyclosporine.
Suzuki S; Kanashiro M; Amemiya H
Transplantation; 1987 Oct; 44(4):483-7. PubMed ID: 3313835
[TBL] [Abstract][Full Text] [Related]
13. A non-lymphocyte-depleting monoclonal antibody to the adhesion molecule LFA-1 (CD11a) prevents sensitization to alloantigens and effectively prolongs the survival of heart allografts.
Nakakura EK; McCabe SM; Zheng B; Shorthouse RA; Scheiner TM; Blank G; Jardieu PM; Morris RE
Transplant Proc; 1993 Feb; 25(1 Pt 1):809-12. PubMed ID: 8438493
[No Abstract] [Full Text] [Related]
14. Efficacy of didemnin B in suppressing allograft rejection in mice and rats.
Yuh DD; Zurcher RP; Carmichael PG; Morris RE
Transplant Proc; 1989 Feb; 21(1 Pt 1):1141-3. PubMed ID: 2650081
[No Abstract] [Full Text] [Related]
15. 15-Deoxyspergualin potentiates the immunosuppressive effect of cyclosporine A in a rat heart allograft model.
Gannedahl G; Wanders A; Carlsson M; Tufveson G
Transplant Proc; 1993 Feb; 25(1 Pt 1):768-9. PubMed ID: 8438473
[No Abstract] [Full Text] [Related]
16. Effects of cyclosporine and 15-deoxyspergualin on coronary arteriosclerosis after heart transplantation in the rat.
Nagamine S; Ohmi M; Tabayashi K; Iguchi A; Mohri H
J Heart Lung Transplant; 1994; 13(5):895-8. PubMed ID: 7803433
[TBL] [Abstract][Full Text] [Related]
17. Prolonged survival of small intestinal allograft in the rat with cyclosporine A, FK 506, and 15-deoxyspergualin.
Iga C; Okajima K; Takeda Y; Tezuka K
Transplant Proc; 1990 Aug; 22(4):1658. PubMed ID: 1697118
[No Abstract] [Full Text] [Related]
18. Synergistic effect of 15-deoxyspergualin and cyclosporine in prolonging survival of rat cardiac allografts.
Kaji H; Chou DT; Sutherland DE; Stephanian E; Gores PF
Transplant Proc; 1994 Apr; 26(2):869-70. PubMed ID: 8171689
[No Abstract] [Full Text] [Related]
19. Beneficial effect of 15-deoxyspergualin on accelerated rejection in rat heart transplantation.
Ueda H; Itoh S; Kusaka M; Isurugi K
Transplant Proc; 1995 Feb; 27(1):420-2. PubMed ID: 7879046
[No Abstract] [Full Text] [Related]
20. Synergistic effects of Isatis tinctoria L. and tacrolimus in the prevention of acute heart rejection in mice.
Wang Y; Qin Q; Chen J; Kuang X; Xia J; Xie B; Wang F; Liang H; Qi Z
Transpl Immunol; 2009 Dec; 22(1-2):5-11. PubMed ID: 19766187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
